CTYX Financials 07/16/2014 07:42:58 Connectyx Tec
Post# of 25
Posted On: 07/16/2014 8:42:54 AM
CTYX Financials 07/16/2014 07:42:58
Connectyx Technologies Holdings Group, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012
Total Revenue 324 134
Cost of Revenue 16 28
Gross Profit 308 106
Operating Expenses
Research and Development - -
Sales, General and Admin. 340 350
Non-Recurring Items - 28
Other 10 15
Operating Income (42) (286)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (42) (286)
Interest Expense 22 20
Earnings Before Tax (63) (306)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (63) (306)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (63) (306)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (63) (306)
Connectyx Technologies Holdings Group, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012
Total Revenue 324 134
Cost of Revenue 16 28
Gross Profit 308 106
Operating Expenses
Research and Development - -
Sales, General and Admin. 340 350
Non-Recurring Items - 28
Other 10 15
Operating Income (42) (286)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (42) (286)
Interest Expense 22 20
Earnings Before Tax (63) (306)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (63) (306)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (63) (306)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (63) (306)
(0)
(0)Curative Biotechnology Inc (CUBT) Stock Research Links
Scroll down for more posts ▼